| Structure |
Chemical Name |
CAS |
MF |
 |
Zilucoplan |
1841136-73-9 |
(C2H4O)nC126H186N24O32 |
 |
Bexagliflozin |
1118567-05-7 |
C24H29ClO7 |
 |
Disitamab Vedotin |
2136633-23-1 |
|
 |
Ixazomib citrate |
1239908-20-3 |
C20H23BCl2N2O9 |
 |
GRT6005 |
863513-91-1 |
C24H27FN2O |
 |
CMLD-2 |
958843-91-9 |
C31H31NO6 |
 |
Romiplostim |
267639-76-9 |
C15H14N2O |
 |
Triptorelin acetate |
140194-24-7 |
C64H82N18O13.C2H4O2 |
 |
Sovilnesib |
2410796-79-9 |
C26H34F2N6O4S |
 |
Eslicarbazepine |
104746-04-5 |
C15H14N2O2 |
|
|
Retatrutide |
2381089-83-2 |
|
 |
4-hydroxy-N'-(2-naphthylmethylene)benzohydrazide |
303760-60-3 |
C18H14N2O2 |
 |
Ivosidenib |
1448347-49-6 |
C28H22ClF3N6O3 |
 |
Pemigatinib |
1513857-77-6 |
C24H27F2N5O4 |
 |
Narmafotinib |
1393653-34-3 |
C28H32F3N5O2 |
 |
MRTX-1719 |
2630904-45-7 |
C23H18ClFN6O2 |
 |
APG-2449 |
2196186-84-0 |
C33H42ClN5O4S |
 |
Enarodustat |
1262132-81-9 |
C17H16N4O4 |
 |
(+)-Fluprostenol |
54276-17-4 |
C23H29F3O6 |
 |
AZD-1208 |
1204144-28-4 |
C21H21N3O2S |
 |
Leniolisib |
1354690-24-6 |
C21H25F3N6O2 |
 |
Pralsetinib |
2097132-94-8 |
C27H32FN9O2 |
 |
IMD-0354 |
978-62-1 |
C15H8ClF6NO2 |
 |
BAY 11-7085 |
196309-76-9 |
C13H15NO2S |
![2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride](/CAS/GIF/694433-59-5.gif) |
2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride |
694433-59-5 |
C20H21N3O2 |
 |
IWP-2 |
686770-61-6 |
C22H18N4O2S3 |
 |
P-5091 |
882257-11-6 |
C12H7Cl2NO3S2 |
 |
SANT-1 |
304909-07-7 |
C23H27N5 |
 |
TAS-116 |
1260533-36-5 |
C25H26N8O |
 |
ICG-001 |
780757-88-2 |
C33H32N4O4 |
 |
Osilodrostat phosphate |
1315449-72-9 |
C13H13FN3O4P |
 |
TPCA-1 |
507475-17-4 |
C12H10FN3O2S |
![1-[1-(4-Fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-pyrrolidinyl)ethanone](/CAS/GIF/314245-33-5.gif) |
1-[1-(4-Fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-pyrrolidinyl)ethanone |
314245-33-5 |
C18H21FN2O |
 |
Donafenib |
1130115-44-4 |
C21H16ClF3N4O3 |
 |
BMS 833923 |
1059734-66-5 |
C30H27N5O |
 |
KGN |
4727-31-5 |
C20H15NO3 |
 |
Ripretinib |
1442472-39-0 |
C24H21BrFN5O2 |
 |
LDN-57444 |
668467-91-2 |
C17H11Cl3N2O3 |
 |
Wnt-C59 |
1243243-89-1 |
C25H21N3O |
![2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[N,N-dimethylbenzenamine](/CAS/GIF/500579-04-4.gif) |
2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[N,N-dimethylbenzenamine |
500579-04-4 |
C27H35N5 |
 |
BMS707035 |
729607-74-3 |
C17H19FN4O5S |
 |
Mitapivat |
1260075-17-9 |
C24H26N4O3S |
 |
GO 6983 |
133053-19-7 |
C26H26N4O3 |
 |
6-AMINO-4-(4-PHENOXYPHENYLETHYLAMINO)QUINAZOLINE |
545380-34-5 |
C22H20N4O |
 |
SC-514 |
354812-17-2 |
C9H8N2OS2 |
 |
IWR-1-endo |
1127442-82-3 |
C25H19N3O3 |
 |
SGI-1776 |
1025065-69-3 |
C20H22F3N5O |
 |
Glasdegib |
1095173-27-5 |
C21H22N6O |
 |
NMS 873 |
1418013-75-8 |
C27H28N4O3S2 |
 |
4-METHYL-N1-(3-PHENYLPROPYL)BENZENE-1,2-DIAMINE |
749886-87-1 |
C16H20N2 |
![3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione](/CAS2/GIF/425637-18-9.gif) |
3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione |
425637-18-9 |
C25H22N6O2 |
 |
KY0211 |
1118807-13-8 |
C18H17ClN2O3S |
 |
Conteltinib
(CT-707) |
1384860-29-0 |
C32H45N9O3S |
 |
RO-31-8220 |
138489-18-6 |
C25H23N5O2S |
 |
2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol |
128607-22-7 |
C24H23ClO2 |
 |
VX 702 |
745833-23-2 |
C19H12F4N4O2 |
 |
PH 797804 |
586379-66-0 |
C22H19BrF2N2O3 |
 |
PF03716556 |
928774-43-0 |
C22H26N4O3 |
 |
CFTRinh-172 |
307510-92-5 |
C18H10F3NO3S2 |
 |
SCH772984 |
942183-80-4 |
C33H33N9O2 |
 |
PD318088 |
391210-00-7 |
C16H13BrF3IN2O4 |
 |
SB 225002 |
182498-32-4 |
C13H10BrN3O4 |
 |
SKI II |
312636-16-1 |
C15H11ClN2OS |
 |
S3I-201 |
501919-59-1 |
C16H15NO7S |
 |
JAK3 Inhibitor |
211555-04-3 |
C16H14BrN3O3 |
 |
AZ 628 |
878739-06-1 |
C27H25N5O2 |
 |
CP 945598 hydrochloride |
686347-12-6 |
C25H26Cl3N7O |
 |
Tezacaftor |
1152311-62-0 |
C26H27F3N2O6 |
 |
Zibotentan (ZD4054) |
186497-07-4 |
C19H16N6O4S |
 |
Galeterone |
851983-85-2 |
C26H32N2O |
 |
Erteberel (LY500307) |
533884-09-2 |
C18H18O3 |
 |
Tenovin-6 |
1011557-82-6 |
C25H34N4O2S |
 |
AZD3514 |
1240299-33-5 |
C25H32F3N7O2 |
 |
KPT-185 |
1333151-73-7 |
C16H16F3N3O3 |
 |
GLPG0634 |
1206101-20-3 |
C23H18N6O2 |
 |
Pifithrin-μ |
64984-31-2 |
C8H7NO2S |
 |
SL 327 |
305350-87-2 |
C16H12F3N3S |
![5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide](/CAS/GIF/868273-06-7.gif) |
5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide |
868273-06-7 |
C24H28ClN3O |
 |
MK 3207 hydrochloride |
957116-20-0 |
C31H30ClF2N5O3 |
 |
TAK-733 |
1035555-63-5 |
C17H15F2IN4O4 |
 |
iOWH-032 |
1191252-49-9 |
C22H15Br2N3O4 |
 |
(R,S)-AM1241 |
444912-48-5 |
C22H22IN3O3 |
![N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thienyl-2-yl)-1-naphthalenecarboxamide](/CAS/20150408/GIF/312917-14-9.gif) |
N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thienyl-2-yl)-1-naphthalenecarboxamide |
312917-14-9 |
C20H16N2OS |
 |
BIX 02189 |
1094614-85-3 |
C27H28N4O2 |
 |
Filgotinib |
1206161-97-8 |
C21H23N5O3S |
 |
Skepinone-L |
1221485-83-1 |
C24H21F2NO4 |
 |
TAK-632 |
1228591-30-7 |
C27H18F4N4O3S |
 |
FH 535 |
108409-83-2 |
C13H10Cl2N2O4S |
 |
LCL-161 |
1005342-46-0 |
C26H33FN4O3S |
 |
U0126-EtOH |
1173097-76-1 |
C20H22N6OS2 |
 |
LCZ696 |
936623-90-4 |
C48H58N6O8 |
 |
Stattic |
19983-44-9 |
C8H5NO4S |
 |
LY2228820 |
862507-23-1 |
C26H37FN6O6S2 |
 |
Binimetinib |
606143-89-9 |
C17H15BrF2N4O3 |
 |
WP1066 |
857064-38-1 |
C17H14BrN3O |
 |
PACRITINIB |
937272-79-2 |
C28H32N4O3 |
 |
(-)-Blebbistatin |
856925-71-8 |
C18H16N2O2 |
 |
Plinabulin(NPI-2358) |
714272-27-2 |
C19H20N4O2 |
 |
OMecaMtiv Mecarbil |
873697-71-3 |
C20H24FN5O3 |
 |
KI16425 |
355025-24-0 |
C23H23ClN2O5S |